An NIH-funded study found deep learning tools could forecast next-day relapse risk with high accuracy, giving clinicians time to intervene.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback